Standard BioTools Inc.（LAB）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · LAB · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$85.33M	$174.43M	$106.34M	$97.95M	$130.58M
Cost of Revenue	$42.79M	$90.17M	$55.89M	$60.90M	$61.21M
Gross Profit	$42.54M	$84.26M	$50.45M	$37.05M	$69.37M
Gross Margin %(computed)	49.86%	48.31%	47.44%	37.83%	53.13%
Operating Expenses
R&D Expenses	$25.99M	$62.41M	$25.95M	$37.38M	$37.94M
G&A Expenses	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Total Operating Expenses	$135.85M	$259.50M	$127.05M	$153.26M	$136.83M
Operating Income	($93.31M)	($175.24M)	($76.60M)	($116.20M)	($67.46M)
Operating Margin %(computed)	-109.34%	-100.46%	-72.03%	-118.64%	-51.66%
Interest Income	$9.18M	$20.20M	$5.57M	$2.23M	$0.00M
Interest Expense	$0.03M	$3.32M	$4.57M	$4.33M	$3.82M
Income Before Tax	($96.70M)	($138.31M)	($74.20M)	($192.93M)	($63.66M)
Income Tax Expense	($37.88M)	$0.57M	$0.45M	($2.83M)	($4.42M)
Net Income	($74.90M)	($138.88M)	($74.66M)	($190.10M)	($59.24M)
Net Margin %(computed)	-87.77%	-79.62%	-70.21%	-194.08%	-45.36%
Per Share & EBITDA
EPS (Basic)	$-0.20	$-0.52	$-0.94	$-2.43	$-0.78
Wtd Avg Shares	381.62M	352.67M	79.16M	78.31M	75.79M
EBITDA	($86.32M)	($118.14M)	($54.46M)	($173.57M)	($44.27M)
EBITDA Margin %(computed)	-101.16%	-67.73%	-51.21%	-177.21%	-33.90%